Clinical trial
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
NCT00253474 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00253474 |
|---|---|
| Title | PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma |
| Official title | A Phase I Trial of Peginterferon Alfa-2b (PEG-Intron) for Plexiform Neurofibromas |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | PEG-interferon alfa-2a |
| Enrollment | 36 |
| Start date | Sep 1, 2005 |
| Completion | Jan 1, 2011 |
| First posted | Nov 15, 2005 |
| Last update posted | Mar 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: